Organ transplant recipients (OTRs) treated with azathioprine (AZA) face an increased risk for nonmelanoma skin cancer (NMSC), particularly squamous cell carcinoma (SCC), according to an updated ...

Bhavana (Tina) Bhatnagar, DO, advocates for AI and diverse clinical trials to bridge equity gaps in precision oncology and value-based care.

ACOs entering MSSP with higher spending were consistently more likely to earn bonuses—a gap that persisted after a 2017 ...

Today, the FDA granted accelerated approval to zongertinib (Hernexeos; Boehringer Ingelheim Pharmaceuticals, Inc.) for an expanded indication for adults with unresectable or metastatic non-squamous ...

Emerging CRC diagnostic tools along with better public awareness could help reverse rising deaths in younger adults, says Jordan Karlitz, MD.

Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

Both approaches identified hemoglobin as one of the most significant predictors of CKD risk. Additional top-ranked features included blood urea, sodium levels, red blood cell count, potassium, and ...

The mood surrounding US HIV policy in 2026 is markedly different from the cautious optimism that defined much of the past decade. What had once felt like a steady march toward ending the domestic ...

Sweeping federal funding cuts and stalled prevention efforts are unraveling hard-won gains in HIV research and access, warns Peter Staley.

Low-cost, scalable interventions can improve first-fill adherence, reduce avoidable hospitalizations, and support patient-centered strategies.

Shane Hochradel, COO of Health Solutions at Elevance Health, oversees operations to power Elevance Health’s partnership with care providers. Elevance Health's Shane Hochradel explains how the company ...

Reducing administrative burden is treated as a strategic lever to improve clinical throughput and patient care quality by ...